| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.161.567.162 $ | +837.530.874 $ | -2,2 % | 5 | 324.036.288 $ | +31.416.290 $ | +4,2 % | 4 | 292.619.998 $ | +24.154.083 $ | +25,2 % | 4 | ||||
| Generate Biomedicines, Inc. | GENB | → 0 | Stark | 783.413.963 $ | +783.413.963 $ | 1 | |||||||||
| Moderna, Inc. | MRNA | → 0 | Neutral | 235.313.169 $ | +98.711.094 $ | +72,3 % | 1 | 136.602.075 $ | +16.953.666 $ | +14,2 % | 1 | 119.648.409 $ | -8.152.582 $ | -6,4 % | 1 |
| Sana Biotechnology, Inc. | SANA | → 0 | Schwach | 72.005.346 $ | -29.752.209 $ | -29,2 % | 1 | 101.757.555 $ | +13.000.966 $ | +14,6 % | 1 | 88.756.589 $ | +20.501.522 $ | +30,0 % | 1 |
| Foghorn Therapeutics Inc. | FHTX | → 0 | Neutral | 60.582.294 $ | -7.857.953 $ | -11,5 % | 1 | 68.440.247 $ | +6.463.801 $ | +10,4 % | 1 | 61.976.446 $ | +2.408.081 $ | +4,0 % | 1 |
| Seres Therapeutics, Inc. | MCRB | → 0 | Neutral | 10.252.390 $ | -6.984.021 $ | -40,5 % | 1 | 17.236.411 $ | -5.002.143 $ | -22,5 % | 1 | 22.238.554 $ | +9.397.062 $ | +73,2 % | 1 |
| 1.161.567.162 $ | +837.530.874 $ | -2,2 % | 5 | 324.036.288 $ | +31.416.290 $ | +4,2 % | 4 | 292.619.998 $ | +24.154.083 $ | +25,2 % | 4 | ||||